Pharmafile Logo
Pharmafocus logo
Advanced Search

crispr

Showing 12 posts of 27 posts found.

dna

US scientists carry out first editing of human embryos

July 28, 2017
Medical Communications, Research and Development biotech, crispr, drugs, gene editing, gene-editing, pharma, pharmaceutical

In what will be regarded as a watershed moment, scientists working at Oregon Health and Science University have used CRISPR …

News
shutterstock_146497481

Gene-editing tool CRISPR found to cause unintentional mutations in live animal models

May 30, 2017
Manufacturing and Production, Research and Development crispr

Gene-editing has been heralded as a wonder tool which could lead to huge advances in a wide range of treatment …

News
pharmafocus_march_cover

The March 2017 issue of Pharmafocus is now live!

February 22, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, FDA, Johnson & Johnson, MSD, Roche, Trump, crispr, immunotherapy, opdivo

The latest edition of Pharmafocus is available to read online now! From breakthroughs in antibiotic resistance R&D to gene editing …

News
shutterstock_146497481

US panel endorses human embryo gene editing, with caveats

February 15, 2017
Research and Development crispr, gene editing

Gene editing in human embryos has been given the go-ahead by a panel of experts from the US National Academy …

News
dna-163466

China conducts first gene-editing human trial

November 21, 2016
Research and Development, Sales and Marketing China, DNA, cas9, crispr

China has used Crispr/Cas9 gene-editing technology to edit the DNA of a human subject, suffering from metastatic lung cancer. This …

News
shutterstock_123182704

Horizon and Fulcrum Therapeutics form CRISPR collaboration

September 6, 2016
Manufacturing and Production, Research and Development Horizon Discovery, crispr, fulcrum, fulcrum therapeutics, gene editing, horizon, rare diseases

Horizon Discovery has announced that it has entered into a partnership with Fulcrum Therapeutics to utilise Horizon’s CRISPR-based screening platform …

News
casebia

Bayer’s CRISPR venture opens for business in biotech hub

August 23, 2016
Manufacturing and Production, Research and Development Bayer, casebia, crispr, gene editing, gene-editing

Bayer and CRISPR Therapeutics have joined together to launch Casebia Therapeutics and have chosen Cambridge, Massachusetts, as its base to …

News
lab

Federal panel to review proposal for first human CRISPR test

June 20, 2016
Research and Development, Sales and Marketing crispr, gene editing, human testing, oncology

A US Federal safety board is set to review a proposal for the first human use of the gene editing …

News
regeneron

Regeneron agrees six-year $75 million upfront licencing deal with Intellia for gene technology

April 12, 2016
Manufacturing and Production, Research and Development, Sales and Marketing IPO, Intellia Therapeutics, Licencing, Regeneron Pharmaceuticals, crispr, deal, gene editing, genetics

Regeneron Pharmaceuticals Inc (Nasdaq: REGN) on Tuesday said it has signed a six-year licencing deal with biotech firm Intellia Therapeutics …

News
hiv-infected_h9_t-cell_-_credit_national_institutes_of_health-web

HIV successfully overcomes CRISPR gene-editing technology

April 8, 2016
Research and Development HIV, crispr, failure, setback

Researchers using the CRISPR gene-editing technology have indicated that HIV can defeat efforts to cripple it, but have characterised it …

News
AZ image

AstraZeneca dives into gene editing

January 29, 2015
Research and Development, Sales and Marketing AstraZeneca, Intellia Therapetics, Novartis, Thermo Fisher Scientific, Wellcome Trust Sanger Institute in Cambridge, Whitehead, broad institute, crispr, the Innovative Genomics Initiative in California

AstraZeneca is looking to harness the power of a pioneering genome-editing tool in a series of new collaborations. The UK …

News
dna image

UK to launch DNA database

November 8, 2013
Sales and Marketing DNA, UK, crispr, genome

Volunteers prepared to share their DNA with the rest of the world are being sought by scientists in the UK, …

News

Latest content

FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer

May 17, 2024

AstraZeneca shares results from phase 3 trial of COVID-19 prevention drug

May 17, 2024

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024